Search results
Author(s):
G Michael Felker
,
Christopher B Granger
Added:
3 years ago
Chronic heart failure is common, disabling and deadly. It affects approximately five million people in the US and accounts for over one million hospitalizations annually. Despite continued improvements in heart failure therapy, mortality over five years is approximately 50%.This article summarizes significant recent developments in pharmacologic and device therapy for heart failure.
Angiotensin…
View more
Author(s):
Rhian E Davies
,
J Dawn Abbott
Added:
3 years ago
Percutaneous Coronary Intervention for Clinical Syndromes
Stable Angina
The primary benefit of percutaneous coronary intervention (PCI) over medical therapy in patients with stable angina is the improved quality of life. The PCI in stable angina (ORBITA) trial was the first sham-controlled trial of PCI where 200 medically optimized patients with single vessel disease were randomized to PCI or…
View more
Author(s):
Maria Teresa La Rovere
,
Roberto Maestri
,
Gian Domenico Pinna
Added:
3 years ago
Arterial baroreceptors play a crucial role in the adjustment of the cardiovascular system to several surrounding conditions. In a simplified paradigm, baroreceptor stimulation results in arterial pressure changes that can modulate both sympathetic and vagal activity and, as a consequence, heart rate and myocardial electrophysiological properties, contractility and vascular resistance. Arterial…
View more
Author(s):
Abdulrahman Almoghairi
,
Nayef Al-Asiri
,
Khalid Al Johani
,
et al
Added:
8 months ago
Author(s):
Jimmy Kerrigan
,
Timir K Paul
,
Jay Patel
,
et al
Added:
5 months ago
Author(s):
Erik B Friedrich
,
Michael Böhm
Added:
3 years ago
Chronic heart failure (CHF) is a major public health problem in industrialized societies with an incidence approaching 10 per 1,000 population after age 65 and an age-dependent prevalence of less than 1% between ages 45-55, 2-5% between ages 65-75, and approximately 10% for patients aged 80 years or more.Thus, HF is primarily a condition of the elderly and approximately 80% of patients…
View more
Author(s):
John S Rumsfeld
,
Gregory J Dehmer
,
Ralph G Brindis
Added:
3 years ago
High-quality healthcare is that which increases “the likelihood of desired health outcomes and is consistent with standards of health care.”1 Inherent in such a definition is the critical role of measurement of patient outcomes and the ‘standards of healthcare,’ such as those reflected in evidence-based clinical practice guidelines.2 Unfortunately, when the quality of healthcare in the US is…
View more
Author(s):
G Michael Felker
,
Christopher B Granger
Added:
3 years ago
Chronic heart failure is common, disabling and deadly. It affects approximately five million people in the US and accounts for over one million hospitalizations annually.1 Despite continued improvements in heart failure therapy, mortality over five years is approximately 50%.2 This article summarizes significant recent developments in pharmacologic and device therapy for heart failure.
…
View more
BAV: SAVR versus TAVR
Author(s):
Arthur J Lee
,
Imran Baig
,
Katherine B Harrington
,
et al
Added:
1 year ago
Article
Author(s):
Erik B Friedrich
,
Michael Böhm
Added:
3 years ago
Chronic heart failure (CHF) is a major public health problem in industrialized societies, with an incidence approaching 10 per 1,000 population after age 65 and an age-dependent prevalence of less than 1% between ages 45 and 55, 2-5% between ages 65 and 75, and approximately 10% for patients aged 80 years or more.1-3 Thus, HF is primarily a condition of the elderly, and approximately 80% of…
View more